Home LiteratureArticle Details
PMID: 9989981 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo.

The Journal of experimental medicine ·Vol. 189 ·No. 4 ·1999-02-15 ·Pages 663-72

Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW

Abstract

Mechanisms responsible for neuroattenuation of herpes simplex virus (HSV) have been defined previously by studies of mutant viruses in cultured cells. The hypothesis that null mutations in host genes can override the attenuated phenotype of null mutations in certain viral genes was tested. Mutants such as those in infected cell protein (ICP) 0, thymidine kinase, ribonucleotide reductase, virion host shutoff, and ICP34.5 are reduced in their capacity to replicate in nondividing cells in culture and in vivo. The replication of these viruses was examined in eyes and trigeminal ganglia for 1-7 d after corneal inoculation in mice with null mutations (-/-) in interferon receptors (IFNR) for type I IFNs (IFN-alpha/betaR), type II IFN (IFN-gammaR), and both type I and type II IFNs (IFN-alpha/beta/gammaR). Viral titers in eyes and ganglia of IFN-gammaR-/- mice were not significantly different from congenic controls. However, in IFN-alpha/betaR-/- or IFN-alpha/beta/gammaR-/- mice, growth of all mutants, including those with significantly impaired growth in cell culture, was enhanced by up to 1,000-fold in eyes and trigeminal ganglia. Blepharitis and clinical signs of infection were evident in IFN-alpha/betaR-/- and IFN-alpha/beta/gammaR-/- but not control mice for all viruses. Also, IFNs were shown to significantly reduce productive infection of, and spread from intact, but not scarified, corneas. Particularly striking was restoration of near-normal trigeminal ganglion replication and neurovirulence of an ICP34.5 mutant in IFN-alpha/betaR-/- mice. These data show that IFNs play a major role in limiting mutant and wild-type HSV replication in the cornea and in the nervous system. In addition, the in vivo target of ICP34.5 may be host IFN responses. These experiments demonstrate an unsuspected role for host factors in defining the phenotypes of some HSV mutants in vivo. The phenotypes of mutant viruses therefore cannot be interpreted based solely upon studies in cell culture but must be considered carefully in the context of host factors that may define the in vivo phenotype.

MeSH Terms
Animals Chlorocebus aethiops Cornea/virology Corneal Injuries Immediate-Early Proteins/genetics,physiology Immunocompetence Interferon-alpha/deficiency,genetics,physiology Interferon-beta/deficiency,genetics,physiology Interferon-gamma/deficiency,genetics,physiology Interferons/deficiency,genetics,physiology Keratitis, Herpetic/physiopathology,virology Mice Mice, Knockout Phenotype Receptor, Interferon alpha-beta Receptors, Interferon/deficiency,genetics,physiology Ribonucleases Ribonucleotide Reductases/genetics,physiology Simplexvirus/drug effects,genetics,isolation & purification,pathogenicity,physiology Thymidine Kinase/genetics,physiology Trigeminal Ganglion/virology Ubiquitin-Protein Ligases Vero Cells Viral Proteins/genetics,physiology Virulence/genetics Virus Replication/genetics
Chemicals
Immediate-Early Proteins Interferon-alpha Receptors, Interferon Viral Proteins gamma 34.5 protein, Human herpesvirus 1 interferon gamma receptor virion host shutoff protein, Simplexvirus Receptor, Interferon alpha-beta Interferon-beta Interferon-gamma Interferons Ribonucleotide Reductases Ubiquitin-Protein Ligases Vmw110 protein, Human herpesvirus 1 Thymidine Kinase Ribonucleases
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Leib D A
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri 63110, USA. leib@am.seer.wustl.edu
Harrison T E
Laslo K M
Machalek M A
Moorman N J
Virgin H W
References (63)
63 references, click to expand
  1. Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-alpha and -gamma.
    J Infect Dis. 1992 Dec;166(6):1401-3 PMID: 1331251
  2. RELATIONSHIP BETWEEN THE ENVELOPE AND THE INFECTIVITY OF HERPES SIMPLEX VIRUS.
    Proc Soc Exp Biol Med. 1964 Mar;115:814-6 PMID: 14155835
  3. A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1.
    J Virol. 1991 Aug;65(8):4078-90 PMID: 1649316
  4. The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice.
    J Infect Dis. 1991 Dec;164(6):1091-7 PMID: 1659596
  5. The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice.
    J Hyg (Lond). 1978 Oct;81(2):267-77 PMID: 212476
  6. Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon.
    J Virol. 1990 May;64(5):2187-92 PMID: 2157880
  7. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture.
    Science. 1990 Nov 30;250(4985):1262-6 PMID: 2173860
  8. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    J Immunol. 1986 May 1;136(9):3481-5 PMID: 2420892
  9. Inhibition of transcription of herpes simplex virus immediate early genes in interferon-treated human cells.
    J Gen Virol. 1988 Jun;69 ( Pt 6):1167-77 PMID: 2455018
  10. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.
    J Virol. 1989 Feb;63(2):759-68 PMID: 2536101
  11. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
    Proc Natl Acad Sci U S A. 1989 Jun;86(12):4736-40 PMID: 2543985
  12. A herpes simplex virus type 1 mutant containing a deletion within immediate early gene 1 is latency-competent in mice.
    J Gen Virol. 1989 Sep;70 ( Pt 9):2501-6 PMID: 2550578
  13. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells.
    Virology. 1989 Nov;173(1):276-83 PMID: 2554573
  14. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant.
    J Virol. 1988 Jan;62(1):196-205 PMID: 2824847
  15. Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription.
    Virology. 1988 May;164(1):201-10 PMID: 2834869
  16. Factor(s) present in herpes simplex virus type 1-infected cells can compensate for the loss of the large subunit of the viral ribonucleotide reductase: characterization of an ICP6 deletion mutant.
    Virology. 1988 Sep;166(1):41-51 PMID: 2842955
  17. Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene.
    Proc Natl Acad Sci U S A. 1985 Aug;82(16):5265-9 PMID: 2991915
  18. Three trans-acting regulatory proteins of herpes simplex virus modulate immediate-early gene expression in a pathway involving positive and negative feedback regulation.
    J Virol. 1985 Dec;56(3):723-33 PMID: 2999428
  19. Identification and separation of the two subunits of the herpes simplex virus ribonucleotide reductase.
    J Virol. 1986 Mar;57(3):1177-81 PMID: 3005618
  20. Retrograde axonal transport of horseradish peroxidase from cornea to trigeminal ganglion.
    Acta Neuropathol. 1977 Apr 29;38(1):49-52 PMID: 300978
  21. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110.
    J Gen Virol. 1986 Dec;67 ( Pt 12):2571-85 PMID: 3025339
  22. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture.
    J Virol. 1987 Mar;61(3):829-39 PMID: 3027408
  23. Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation.
    J Virol. 1987 Jul;61(7):2171-4 PMID: 3035217
  24. Latent herpesvirus infections of neurons in guinea pigs and humans.
    Yale J Biol Med. 1987 Mar-Apr;60(2):159-67 PMID: 3495074
  25. Biochemical studies on the herpes simplex virus-specified deoxypyrimidine kinase activity.
    J Gen Virol. 1974 Sep;24(3):481-92 PMID: 4372300
  26. Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity.
    EMBO J. 1984 Dec 20;3(13):3135-41 PMID: 6098466
  27. Herpes simplex virus mutants defective in the virion-associated shutoff of host polypeptide synthesis and exhibiting abnormal synthesis of alpha (immediate early) viral polypeptides.
    J Virol. 1983 May;46(2):498-512 PMID: 6302315
  28. Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent.
    Virology. 1983 Nov;131(1):171-9 PMID: 6316649
  29. Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis.
    J Virol. 1995 Nov;69(11):6779-86 PMID: 7474089
  30. Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5- mutants of herpes simplex virus 1.
    Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10516-20 PMID: 7479831
  31. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice.
    J Immunol. 1995 Oct 15;155(8):3964-71 PMID: 7561104
  32. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas.
    Nat Med. 1995 Sep;1(9):938-43 PMID: 7585221
  33. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1.
    J Virol. 1995 Aug;69(8):4898-905 PMID: 7609058
  34. An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation.
    J Virol. 1995 May;69(5):3033-41 PMID: 7707530
  35. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections.
    J Virol. 1995 Feb;69(2):904-9 PMID: 7815559
  36. Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 gamma 34.5 mutants in a mouse eye model.
    J Gen Virol. 1995 Feb;76 ( Pt 2):321-32 PMID: 7844554
  37. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus.
    J Virol. 1995 Mar;69(3):1389-99 PMID: 7853471
  38. Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats.
    J Neurooncol. 1994;19(2):137-47 PMID: 7964989
  39. The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency.
    J Virol. 1994 Dec;68(12):8045-55 PMID: 7966594
  40. Functional role of type I and type II interferons in antiviral defense.
    Science. 1994 Jun 24;264(5167):1918-21 PMID: 8009221
  41. The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice.
    J Gen Virol. 1994 Aug;75 ( Pt 8):2059-63 PMID: 8046409
  42. A thymidine kinase-negative HSV-1 strain establishes a persistent infection in SCID mice that features uncontrolled peripheral replication but only marginal nervous system involvement.
    Virology. 1994 Mar;199(2):484-90 PMID: 8122378
  43. Mapping the genetic region coding for herpes simplex virus resistance to mouse interferon alpha/beta.
    J Gen Virol. 1993 Nov;74 ( Pt 11):2325-32 PMID: 8245849
  44. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures.
    J Virol. 1994 Jan;68(1):48-55 PMID: 8254758
  45. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0).
    J Gen Virol. 1993 Dec;74 ( Pt 12):2679-90 PMID: 8277273
  46. In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts.
    J Gen Virol. 1993 Sep;74 ( Pt 9):1859-69 PMID: 8397283
  47. The carboxyl terminus of the murine MyD116 gene substitutes for the corresponding domain of the gamma(1)34.5 gene of herpes simplex virus to preclude the premature shutoff of total protein synthesis in infected human cells.
    J Virol. 1996 Jan;70(1):84-90 PMID: 8523596
  48. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
    J Virol. 1996 Feb;70(2):1271-6 PMID: 8551594
  49. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled.
    J Immunol. 1996 May 15;156(10):3901-10 PMID: 8621929
  50. The role of the innate immune system in the reconstituted SCID mouse model of herpetic stromal keratitis.
    Clin Immunol Immunopathol. 1996 Jul;80(1):23-30 PMID: 8674236
  51. Inhibition of herpes simplex virus type 1 immediate-early gene expression by alpha interferon is not VP16 specific.
    J Virol. 1996 Sep;70(9):6336-9 PMID: 8709261
  52. Effect of interferon-alpha on the steady-state levels of thymine, thymidine, guanine, and guanosine metabolites in herpes simplex virus-type 1-infected cells.
    Intervirology. 1995;38(5):249-55 PMID: 8724854
  53. Role of cis-acting sequences of the ICPO promoter of herpes simplex virus type 1 in viral pathogenesis, latency and reactivation.
    J Gen Virol. 1996 Aug;77 ( Pt 8):1853-63 PMID: 8760437
  54. Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0.
    J Virol. 1996 Nov;70(11):7471-7 PMID: 8892865
  55. The virion host shutoff function of herpes simplex virus type 1 plays a role in corneal invasion and functions independently of the cell cycle.
    Virology. 1997 Apr 28;231(1):28-34 PMID: 9143299
  56. The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27.
    J Virol. 1997 Jun;71(6):4614-25 PMID: 9151855
  57. Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis.
    J Virol. 1997 Sep;71(9):6850-62 PMID: 9261410
  58. Innate and acquired immunity to herpes simplex virus type 1.
    Virology. 1997 Sep 29;236(2):328-37 PMID: 9325240
  59. Interferon-gamma protects against herpes simplex virus type 1-mediated neuronal death.
    Virology. 1997 Nov 24;238(2):189-97 PMID: 9400592
  60. Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response.
    J Exp Med. 1998 Feb 2;187(3):341-8 PMID: 9449714
  61. The BglII-N fragment of herpes simplex virus type 2 contains a region responsible for resistance to antiviral effects of interferon.
    J Gen Virol. 1998 Mar;79 ( Pt 3):565-72 PMID: 9519835
  62. The comparative anti-herpes simplex virus effects of human interferons.
    J Interferon Cytokine Res. 1998 Mar;18(3):159-65 PMID: 9555977
  63. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting.
    Gene Ther. 1998 Apr;5(4):440-50 PMID: 9614567
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1999-02-15
Pages
663-72
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2192939
Subset
IM
Grants
NEI NIH HHS · R01 EY09083 · United States
NEI NIH HHS · R01 EY009083 · United States
NIAID NIH HHS · R01 AI39616 · United States
NEI NIH HHS · R01 EY010707 · United States
NEI NIH HHS · P30-EY02687 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com